BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2016

Aug 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2016-08-11

Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-11	Common Stock	S	1306	$5.05	Disposed	128745	Direct
2016-08-12	Common Stock	S	4558	$5.22	Disposed	124187	Direct

Footnotes

F1: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.20 to $5.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.